AIRLINK 74.60 Decreased By ▼ -0.65 (-0.86%)
BOP 5.14 Increased By ▲ 0.03 (0.59%)
CNERGY 4.50 Decreased By ▼ -0.10 (-2.17%)
DFML 33.00 Increased By ▲ 0.47 (1.44%)
DGKC 88.90 Decreased By ▼ -1.45 (-1.6%)
FCCL 22.55 Decreased By ▼ -0.43 (-1.87%)
FFBL 32.70 Decreased By ▼ -0.87 (-2.59%)
FFL 9.84 Decreased By ▼ -0.20 (-1.99%)
GGL 10.88 Decreased By ▼ -0.17 (-1.54%)
HBL 115.31 Increased By ▲ 0.41 (0.36%)
HUBC 136.63 Decreased By ▼ -0.71 (-0.52%)
HUMNL 9.97 Increased By ▲ 0.44 (4.62%)
KEL 4.63 Decreased By ▼ -0.03 (-0.64%)
KOSM 4.70 No Change ▼ 0.00 (0%)
MLCF 39.70 Decreased By ▼ -0.84 (-2.07%)
OGDC 138.96 Decreased By ▼ -0.79 (-0.57%)
PAEL 26.89 Decreased By ▼ -0.76 (-2.75%)
PIAA 25.15 Increased By ▲ 0.75 (3.07%)
PIBTL 6.84 Decreased By ▼ -0.08 (-1.16%)
PPL 122.74 Decreased By ▼ -2.56 (-2.04%)
PRL 27.01 Decreased By ▼ -0.54 (-1.96%)
PTC 14.00 Decreased By ▼ -0.15 (-1.06%)
SEARL 59.47 Decreased By ▼ -2.38 (-3.85%)
SNGP 71.15 Decreased By ▼ -1.83 (-2.51%)
SSGC 10.44 Decreased By ▼ -0.15 (-1.42%)
TELE 8.65 Decreased By ▼ -0.13 (-1.48%)
TPLP 11.51 Decreased By ▼ -0.22 (-1.88%)
TRG 65.13 Decreased By ▼ -1.47 (-2.21%)
UNITY 25.80 Increased By ▲ 0.65 (2.58%)
WTL 1.41 Decreased By ▼ -0.03 (-2.08%)
BR100 7,819 Increased By 16.2 (0.21%)
BR30 25,577 Decreased By -238.9 (-0.93%)
KSE100 74,664 Increased By 132.8 (0.18%)
KSE30 24,072 Increased By 117.1 (0.49%)
Editorials

Gene-editing tech could make people immune to flu, HIV in future

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology
Published February 16, 2019 Updated February 18, 2019

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology, people could soon go immune to flu or even HIV.

Researchers at the Fred Hutchinson Cancer Research Center have developed a new technique for artificially creating advanced and longer-lasting antibodies by gene-editing the DNA of B cells – immune systems white blood cells responsible for creating antibodies.

As per Futurism, several traditional antibody treatments are only effective for a short time period; antibodies tend to break down rapidly, later requiring additional injections. According to scientists, their technique can ultimately allow doctors to overcome this hurdle since the new antibodies would only need to be injected once.

Chinese scientists clone gene-edited monkeys for disease research

The research published in the journal bioRxiv described that initial tests involved 15 mice and showed promising results, providing 82 days of protection against the respiratory syncytial virus (RSV) – a respiratory tract infection that can prove dangerous for children and adults both.

Moreover, according to New Scientist, despite gene-editing being a rapidly growing trend, scientists still need to prove the technique completely safe, which might take few years. But, according to the research, if the technology ever becomes treatment for humans in future, ‘thousands of hospital visits, disabilities, and death could be prevented each year’.

Copyright Business Recorder, 2019

Comments

Comments are closed.